Mitochondrial aldehyde dehydrogenase (ALDH2) as a new target for anti-atherosclerotic drugs
2011/01/N/NZ4/01145
Keywords
Descriptors
- NZ4_17: Farmakologia
- NZ2_3: Proteomika
Panel
NZ4 – Biology of tissues, organs and organisms: morphology and functions of animal's and human's systems, organs and organisms, experimental medicine, basics of neurology
Host institution
Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski
Voivodeship: małopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 1 – announced on 2011-03-15
- Amount awarded
- 166 300 PLN
- Project start date
- 2011-12-16
- Project end date
- 2014-05-15
- Project duration
- 29 months (the same as in the proposal)
- Project status
- Project settled
Equipment purchased [PL]
- MicroRotofor. Cost: 35 000 PLN
Information in the final report
Articles in post-conference publications (1)
-
Proteomic analysis of liver mitochondria of atherosclerotic apoE-knockout mice treated with Alda-1 - an activator of mitochondrial aldehyde dehydrogenase (ALDH2)
- Authors:
- Aneta Stachowicz, Maciej Suski, Rafał Olszanecki, Józef Madej, Anna Wiśniewska, Jacek Jawień, Magdalena Białas, Krzysztof Okoń, Ryszard Korbut
- Conference:
- XVIIIth International Congress of the Polish Pharmacology (year: 2013, pages: 85-86), Publisher: Institute of Pharmacology Polish Academy of Sciences
- Date:
- conference 23-25 maja
- Status:
- Published